STX7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.061900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.191610E-01
Normal-vs-Stage2
4.039700E-03
Normal-vs-Stage3
7.783700E-02
Normal-vs-Stage4
1.958790E-01
Stage1-vs-Stage2
8.818400E-01
Stage1-vs-Stage3
5.334400E-01
Stage1-vs-Stage4
5.689400E-01
Stage2-vs-Stage3
2.858400E-01
Stage2-vs-Stage4
5.003600E-01
Stage3-vs-Stage4
1.578220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.277100E-03
Normal-vs-AfricanAmerican
2.352200E-01
Normal-vs-Asian
2.305700E-02
Caucasian-vs-AfricanAmerican
2.617600E-01
Caucasian-vs-Asian
4.134000E-01
AfricanAmerican-vs-Asian
2.338400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.517700E-03
Normal-vs-Female
4.056000E-03
Male-vs-Female
6.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.574990E-01
Normal-vs-Age(41-60Yrs)
2.738000E-01
Normal-vs-Age(61-80Yrs)
3.978700E-03
Normal-vs-Age(81-100Yrs)
2.446500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.017200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.149400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.848000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.874200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.486200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.895700E-03
Normal-vs-Daily Drinker
1.612240E-01
Normal-vs-Weekly Drinker
8.877900E-03
Normal-vs-Occasional Drinker
2.542500E-02
Normal-vs-Social Drinker
3.575800E-02
Non Drinker-vs-Daily Drinker
8.524200E-02
Non Drinker-vs-Weekly Drinker
4.947000E-01
Non Drinker-vs-Occasional Drinker
7.762600E-01
Non Drinker-vs-Social Drinker
6.815000E-01
Daily Drinker-vs-Weekly Drinker
4.222800E-01
Daily Drinker-vs-Occasional Drinker
7.874100E-02
Daily Drinker-vs-Social Drinker
6.839500E-02
Weekly Drinker-vs-Occasional Drinker
4.064200E-01
Weekly Drinker-vs-Social Drinker
3.577000E-01
Occasional Drinker-vs-Social Drinker
9.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.588500E-02
Normal-vs-Grade 2
9.535100E-03
Normal-vs-Grade 3
1.156250E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.677000E-01
Grade 1-vs-Grade 3
5.635800E-01
Grade 1-vs-Grade 4
9.588500E-02
Grade 2-vs-Grade 3
6.624400E-01
Grade 2-vs-Grade 4
9.535100E-03
Grade 3-vs-Grade 4
1.156250E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.836300E-03
Normal-vs-NonDiabetic
9.402400E-04
Diabetic-vs-NonDiabetic
7.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.905810E-01
Normal-vs-NoPancreatitis
1.980280E-03
Pancreatitis-vs-NoPancreatitis
5.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.442350E-02
Normal-vs-N1
2.402600E-03
N0-vs-N1
9.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.680800E-03
Normal-vs-TP53-NonMutant
1.662000E-02
TP53-Mutant-vs-TP53-NonMutant
5.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
